3-iodobenzylguanidine has been researched along with Glioma in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, J; Hens, M; Koumarianou, E; McDougald, D; Vaidyanathan, G; Zalutsky, MR | 1 |
| Babich, JW; Boyd, M; Gaze, MN; Mairs, RJ; McCluskey, AG; Pimlott, SL | 1 |
| Boyd, M; Braidwood, L; Brown, M; Conner, J; Joyce, C; Mairs, RJ; Pimlott, S; Sorensen, A | 1 |
| Akimoto, J; Haraoka, J; Hashimoto, R; Nakajima, N; Tsutsumi, M | 1 |
| Angerson, WJ; Boyd, M; Clark, AM; Cosimo, E; Gaze, MN; Mairs, RJ; McCluskey, AG; Ross, SC | 1 |
| Kinouchi, H; Mizoi, K; Naitoh, Y; Sasajima, T; Tomura, N; Watarai, J | 1 |
| Biaglow, J; Burd, R; Dewhirst, M; Leeper, D; Tuttle, S | 1 |
| Boyd, M; Brown, SM; Dunn, P; Harland, J; Livingstone, A; Mairs, RJ; Quigg, M; Rampling, R; Wilson, L | 1 |
| Biaglow, JE; Chance, B; Dewhirst, MW; Evans, SM; Glickson, JD; Jenkins, WT; Leeper, D; Manevich, Y; Stevens, C; Tuttle, SW; Wroblewski, K | 1 |
| Wheldon, TE | 1 |
| Boyd, M; Brown, MM; Cunningham, SH; Keith, WN; Livingstone, A; Mairs, RJ; Mairs, SC; Quigg, M; Wilson, L | 1 |
1 review(s) available for 3-iodobenzylguanidine and Glioma
| Article | Year |
|---|---|
Radiation physics and genetic targeting: new directions for radiotherapy. The Douglas Lea Lecture 1999.
Topics: 3-Iodobenzylguanidine; Brain Neoplasms; Genetic Therapy; Glioma; Humans; Neoplasms; Radiopharmaceuticals; Radiotherapy; Sodium Iodide; Transfection; Tumor Cells, Cultured | 2000 |
10 other study(ies) available for 3-iodobenzylguanidine and Glioma
| Article | Year |
|---|---|
Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): A novel 18F-labeled analogue of MIBG.
Topics: 3-Iodobenzylguanidine; Animals; Autoradiography; Fluorine Radioisotopes; Glioma; Guanidines; Iodobenzenes; Isotope Labeling; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Experimental treatment of neuroblastoma using [131I]meta-iodobenzylguanidine and topotecan in combination.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Combined Chemotherapy Protocols; DNA Fragmentation; Glioma; Mice; Mice, Nude; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Radiopharmaceuticals; Topotecan; Treatment Outcome | 2008 |
In vivo evaluation of a cancer therapy strategy combining HSV1716-mediated oncolysis with gene transfer and targeted radiotherapy.
Topics: 3-Iodobenzylguanidine; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Combined Modality Therapy; DNA, Recombinant; Gene Transfer Techniques; Glioma; Herpesvirus 1, Human; Humans; Mice; Molecular Targeted Therapy; Norepinephrine Plasma Membrane Transport Proteins; Oncolytic Viruses; Sequence Deletion; Time Factors | 2012 |
Two cases of posterior reversible encephalopathy syndrome resembling brainstem glioma.
Topics: 3-Iodobenzylguanidine; Adult; Brain; Brain Stem Neoplasms; Catecholamines; Female; Glioma; Hashimoto Disease; Humans; Hypertensive Encephalopathy; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Posterior Leukoencephalopathy Syndrome; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
[131I]meta-iodobenzylguanidine and topotecan combination treatment of tumors expressing the noradrenaline transporter.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Cattle; Cell Line, Tumor; Comet Assay; DNA Damage; DNA Fragmentation; DNA, Complementary; Glioma; Humans; Iodine Radioisotopes; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Time Factors; Topotecan; Transfection | 2005 |
123I-metaiodobenzylguanidine single-photon emission computerized tomography in brain tumors - a preliminary study.
Topics: 3-Iodobenzylguanidine; Adult; Aged, 80 and over; Animals; Brain Neoplasms; Child; Child, Preschool; Diagnosis, Differential; Female; Glioma; Humans; Infant; Magnetic Resonance Imaging; Male; Meningioma; Middle Aged; Neoplasms, Germ Cell and Embryonal; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2006 |
Factors controlling oxygen utilization.
Topics: 3-Iodobenzylguanidine; Animals; Cell Line, Tumor; Diffusion; Female; Glioma; Glucose; Glutamine; Malonates; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Oxygen Consumption; Rats; Succinic Acid | 2005 |
Assessment in vitro of a novel therapeutic strategy for glioma, combining herpes simplex virus HSV1716-mediated oncolysis with gene transfer and targeted radiotherapy.
Topics: 3-Iodobenzylguanidine; Animals; Cell Line; Cell Survival; Combined Modality Therapy; Cricetinae; Dose-Response Relationship, Drug; Gene Transfer Techniques; Genetic Engineering; Glioma; Herpesvirus 1, Human; Humans; In Vitro Techniques; Kinetics; Mice; Norepinephrine Plasma Membrane Transport Proteins; Oncolytic Virotherapy; Radiotherapy; Structure-Activity Relationship; Time Factors; Transduction, Genetic; Tumor Cells, Cultured | 2005 |
MIBG inhibits respiration: potential for radio- and hyperthermic sensitization.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Electron Transport; Flavoproteins; Glioma; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Mitochondria; NADP; Neoplasm Proteins; Oxidation-Reduction; Oxygen Consumption; Phosphorus; Radiopharmaceuticals; Rats; Spectrometry, Fluorescence; Tumor Cells, Cultured | 1998 |
Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell kill.
Topics: 3-Iodobenzylguanidine; Animals; Cattle; Cell Death; Cell Division; Cell Survival; Dose-Response Relationship, Radiation; Genetic Therapy; Glioma; Humans; Norepinephrine Plasma Membrane Transport Proteins; Promoter Regions, Genetic; Radiopharmaceuticals; Symporters; Tumor Cells, Cultured | 2001 |